InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Browse the detailed record of transactions filed by Golembiewski Michael Joseph, 首席财务官. Officer active across 1 company, notably Seelos Therapeutics, INC.. In total, 5 disclosures have been recorded. Split: 1 buy · 0 sell. Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
Golembiewski Michael Joseph is Directeur Financier and Chief Financial Officer at Seelos Therapeutics, INC. His 5 filings, all included in the sample of 5 filings, cover the period from 2022-03-04 to 2024-03-01, and the most frequent transaction nature is Attribution.